Center-Authored Papers

Filters: Author is Bradley, Robert K  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
Zinc Fingers
Ilagan JO, Ramakrishnan A, Hayes B, Murphy ME, Zebari AS, Bradley P, Bradley RK.  2015.  U2AF1 mutations alter splice site recognition in hematological malignancies.. Genome research. 25(1):14-26. Abstract
Vaccine and Infectious Disease Division
Hubert CG, Bradley RK, Ding Y, Toledo CM, Herman J, Skutt-Kakaria K, Girard EJ, Davison J, Berndt J, Corrin P et al..  2013.  Genome-wide RNAi screens in human brain tumor isolates reveal a novel viability requirement for PHF5A.. Genes & development. 27(9):1032-45. Abstract
Specimen Processing Core Facility
Kim E, Ilagan JO, Liang Y, Daubner GM, Lee SC-W, Ramakrishnan A, Li Y, Chung YR, Micol J-B, Murphy ME et al..  2015.  SRSF2 Mutations Contribute to Myelodysplasia by Mutant-Specific Effects on Exon Recognition.. Cancer cell. 27(5):617-30. Abstract
Specialized Pathology Core Facility
Hubert CG, Bradley RK, Ding Y, Toledo CM, Herman J, Skutt-Kakaria K, Girard EJ, Davison J, Berndt J, Corrin P et al..  2013.  Genome-wide RNAi screens in human brain tumor isolates reveal a novel viability requirement for PHF5A.. Genes & development. 27(9):1032-45. Abstract
Shared Resources
Dvinge H, Ries RE, Ilagan JO, Stirewalt DL, Meshinchi S, Bradley RK.  2014.  Sample processing obscures cancer-specific alterations in leukemic transcriptomes.. Proceedings of the National Academy of Sciences of the United States of America. 111(47):16802-7. Abstract
RNA Splicing
Ilagan JO, Ramakrishnan A, Hayes B, Murphy ME, Zebari AS, Bradley P, Bradley RK.  2015.  U2AF1 mutations alter splice site recognition in hematological malignancies.. Genome research. 25(1):14-26. Abstract
RNA Splice Sites
Ilagan JO, Ramakrishnan A, Hayes B, Murphy ME, Zebari AS, Bradley P, Bradley RK.  2015.  U2AF1 mutations alter splice site recognition in hematological malignancies.. Genome research. 25(1):14-26. Abstract
Ribonucleoproteins
Ilagan JO, Ramakrishnan A, Hayes B, Murphy ME, Zebari AS, Bradley P, Bradley RK.  2015.  U2AF1 mutations alter splice site recognition in hematological malignancies.. Genome research. 25(1):14-26. Abstract
Public Health Sciences Division
Hubert CG, Bradley RK, Ding Y, Toledo CM, Herman J, Skutt-Kakaria K, Girard EJ, Davison J, Berndt J, Corrin P et al..  2013.  Genome-wide RNAi screens in human brain tumor isolates reveal a novel viability requirement for PHF5A.. Genes & development. 27(9):1032-45. Abstract
Bradley RK, Merkin J, Lambert NJ, Burge CB.  2012.  Alternative splicing of RNA triplets is often regulated and accelerates proteome evolution.. PLoS biology. 10(1):e1001229. Abstract
Satija R, Bradley RK.  2012.  The TAGteam motif facilitates binding of 21 sequence-specific transcription factors in the Drosophila embryo.. Genome research. 22(4):656-665. Abstract
Proteomics Core Facility
Jagannathan S, Ogata Y, Gafken PR, Tapscott SJ, Bradley RK.  2019.  Quantitative proteomics reveals key roles for post-transcriptional gene regulation in the molecular pathology of FSHD.. eLife. 8 Abstract
Prevention Center Core Facility
Dvinge H, Ries RE, Ilagan JO, Stirewalt DL, Meshinchi S, Bradley RK.  2014.  Sample processing obscures cancer-specific alterations in leukemic transcriptomes.. Proceedings of the National Academy of Sciences of the United States of America. 111(47):16802-7. Abstract
Nuclear Proteins
Ilagan JO, Ramakrishnan A, Hayes B, Murphy ME, Zebari AS, Bradley P, Bradley RK.  2015.  U2AF1 mutations alter splice site recognition in hematological malignancies.. Genome research. 25(1):14-26. Abstract
Mutation
Ilagan JO, Ramakrishnan A, Hayes B, Murphy ME, Zebari AS, Bradley P, Bradley RK.  2015.  U2AF1 mutations alter splice site recognition in hematological malignancies.. Genome research. 25(1):14-26. Abstract
Models, Molecular
Ilagan JO, Ramakrishnan A, Hayes B, Murphy ME, Zebari AS, Bradley P, Bradley RK.  2015.  U2AF1 mutations alter splice site recognition in hematological malignancies.. Genome research. 25(1):14-26. Abstract
May 2013
Hubert CG, Bradley RK, Ding Y, Toledo CM, Herman J, Skutt-Kakaria K, Girard EJ, Davison J, Berndt J, Corrin P et al..  2013.  Genome-wide RNAi screens in human brain tumor isolates reveal a novel viability requirement for PHF5A.. Genes & development. 27(9):1032-45. Abstract
K562 Cells
Ilagan JO, Ramakrishnan A, Hayes B, Murphy ME, Zebari AS, Bradley P, Bradley RK.  2015.  U2AF1 mutations alter splice site recognition in hematological malignancies.. Genome research. 25(1):14-26. Abstract
January 2012
Bradley RK, Merkin J, Lambert NJ, Burge CB.  2012.  Alternative splicing of RNA triplets is often regulated and accelerates proteome evolution.. PLoS biology. 10(1):e1001229. Abstract
Humans
Ilagan JO, Ramakrishnan A, Hayes B, Murphy ME, Zebari AS, Bradley P, Bradley RK.  2015.  U2AF1 mutations alter splice site recognition in hematological malignancies.. Genome research. 25(1):14-26. Abstract
Human Biology Division
Hubert CG, Bradley RK, Ding Y, Toledo CM, Herman J, Skutt-Kakaria K, Girard EJ, Davison J, Berndt J, Corrin P et al..  2013.  Genome-wide RNAi screens in human brain tumor isolates reveal a novel viability requirement for PHF5A.. Genes & development. 27(9):1032-45. Abstract
Histones
Ilagan JO, Ramakrishnan A, Hayes B, Murphy ME, Zebari AS, Bradley P, Bradley RK.  2015.  U2AF1 mutations alter splice site recognition in hematological malignancies.. Genome research. 25(1):14-26. Abstract
Hematologic Neoplasms
Ilagan JO, Ramakrishnan A, Hayes B, Murphy ME, Zebari AS, Bradley P, Bradley RK.  2015.  U2AF1 mutations alter splice site recognition in hematological malignancies.. Genome research. 25(1):14-26. Abstract
Genomics Core Facility
Kim E, Ilagan JO, Liang Y, Daubner GM, Lee SC-W, Ramakrishnan A, Li Y, Chung YR, Micol J-B, Murphy ME et al..  2015.  SRSF2 Mutations Contribute to Myelodysplasia by Mutant-Specific Effects on Exon Recognition.. Cancer cell. 27(5):617-30. Abstract
Ilagan JO, Ramakrishnan A, Hayes B, Murphy ME, Zebari AS, Bradley P, Bradley RK.  2015.  U2AF1 mutations alter splice site recognition in hematological malignancies.. Genome research. 25(1):14-26. Abstract